期刊文献+

PGI_2-PPARδ信号传导途径与哺乳动物的胚胎着床 被引量:2

PGI_2-PPARδ Signal Transduction Pathway in Mammalian Embryo Implantation
下载PDF
导出
摘要 前列腺素 (PGs)在胚泡着床和子宫的蜕膜化过程中起着重要的调节作用 ,前列环素 (PGI2 )是着床位点表达量最高的PGs .前列环素受体 (IP)和过氧化物酶体增殖因子活化受体 (PPARs)分别是PGI2 的细胞表面G蛋白偶联的受体和细胞核内受体 ,IP在胚泡着床位点不表达或检测不到 ,而PPARδ表达丰富 ,RXRs (PPARs的异二聚体伴侣 )及相应的PPARδ RXRα复合物、PGI2 合成酶 (COX 2 /PGIS)也在着床位点表达丰富 ,因此推测PGI2 在胚泡着床中的作用可能是通过PPARδ受体介导的 .利用PGI2 类似物 (cPGI)和PPARδ特异性类似物能够恢复COX 2基因敲除小鼠的胚泡着床和蜕膜化 .总之 ,PGI2 Prostaglandins (PGs) are important in blastocyst implantation and decidualization. The level of PGI 2 was the highest followed by PGE 2 in the site of blastocyst implantation. In addition, PGI 2 level was significantly higher at the implantation sites than inter-implantation sites. IP and PPARs are the G protein-coupled cell surface receptors that are linked to different cytoplasmic signaling pathways and the nuclear hormone receptors, respectively. IP is not expressed or undetectable at implantation sites, but PPARδ expression is very abundant. RXRs (the partner receptor for PPARs), PPARδ-RXRα heterodimer and PGI 2 synthase (COX-2/PGIS) are also abundant at implantation sites. Both PGI 2 agonist (cPGI) and PPARδ specific agonist can restore blastocyst implantation and decidualization in COX-2 -/- mice. These data suggested that PGI 2 may play important roles in blastocyst implantation and decidualization by PPARδ activation.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2003年第4期522-526,共5页 Progress In Biochemistry and Biophysics
基金 国家杰出青年科学基金资助项目 (3 982 5 12 0 ) 国家重点基础研究发展规划项目 (973 ) (G19990 5 5 90 3 )~~
  • 相关文献

参考文献19

  • 1Paria B C, Reese J, Das S K, et al. Deciphering the cross-talk of implantation: Advances and challenges. Science, 2002, 296(5576):2185~2188.
  • 2Lim H, Dey S K. PPAR delta functions as a prostacyclin receptor in blastocyst implantation. Trends Endocrinol Metab, 2000, 11 (4):137~142.
  • 3Chakraborty I, Das S K, Wang J, et al. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol, 1996, 16 (2):107~122.
  • 4Sporn M B, Suh N, Mangelsdorf D J. Prospects for prevention and treatment of cancer with selective PPARgamma modulators(SPARMs). Trends Mol Med, 2001,7 (9):395~400.
  • 5Fajas L, Debril M B, Auwerx J. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. J Mol Endocrinol, 2001, 27 (1): 1~9.
  • 6Lim H, Gupta R A, Ma W G, etal. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev, 1999, 13 (12): 1561~1574.
  • 7Song H, Lim H, Das S K, et al. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Mol Endocrinol, 2000, 14 (8): 1147~1161.
  • 8Lim H, Paria B C, Das S K, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell,1997, 91 (2):197~208.
  • 9Reese J, Brown N, Paria B C, et al. COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period. Mol Cell Endocrinol, 1999, 150 (1~2): 23~31.
  • 10Tarrade A, Schoonjans K, Pavan L, et al. PPARgamma/RXRalpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab, 2001, 86 (10): 5017~5024.

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部